ReviewTherapeutics and clinical risk management2014

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients.

Sooyoung Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.